Latest filing published 21 Feb 2025 for Cullinan Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Corrine Savill: trading record in brief
All filings by Corrine Savill on record concern Cullinan Therapeutics, Inc. Between 11 February 2022 and 19 February 2025, the trades on record add up to 17 filings.
Sales make up the whole of the open-market record (9 sales, €2.4M). Outside the open market, there are 4 share grants and 4 option exercises.
The record was last updated on 21 February 2025 with a share grant in Cullinan Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Corrine Savill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 37,500 shares0Common StockSEC:0000950170-25-025031:0
- 37,500 shares0Common StockSEC:0000950170-24-019463:0
- 40,000 shares@ US$4.3016.2% of flowCommon StockSEC:0000950170-24-010975:0
- 40,000 shares@ US$4.3016.2% of flowCommon StockSEC:0000950170-24-009047:0
- 14,559 shares@ US$4.305.9% of flowCommon StockSEC:0000950170-24-007032:0
- 20,500 shares0Common StockSEC:0000899243-23-005735:0
- 5,042 shares@ US$15.067.6% of flowCommon StockSEC:0000899243-22-026470:0
- 39,800 shares@ US$13.3353.8% of flowCommon StockSEC:0000899243-22-025971:0
- 200 shares@ US$13.850.3% of flowCommon StockSEC:0000899243-22-025971:1
- 16,500 shares0Common StockSEC:0000899243-22-006413:0
10 of 10 declarations
